ClinicalTrials.Veeva

Menu

Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families

The University of Texas System (UT) logo

The University of Texas System (UT)

Status and phase

Completed
Phase 4

Conditions

Smoking Cessation
Environmental Tobacco Smoke

Treatments

Behavioral: Quitline referral
Behavioral: motivational advice
Drug: nicotine replacement therapy (NRT)

Study type

Interventional

Funder types

Other

Identifiers

NCT04045964
HSC-MS-11-0641(Substudy)

Details and patient eligibility

About

The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.

Enrollment

32 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Eligible mothers of any age or ethnic background must have an infant that is at least 1 week prior to the estimated date of hospital discharge in the NICU (ensuring time for the intervention)
  • report that a household resident smokes at least 5 cigarettes per day, on average, within the 2 months preceding the screening visit
  • agree to attend intervention sessions
  • live within 50 miles of our center
  • and have access to a telephone

Exclusion criteria

  • Mothers were ineligible if they met criteria for severe cognitive, and/or psychiatric impairment, per judgment of NICU and research staff, that precludes cooperation with study protocol
  • were unable to read, write, and speak English
  • were unable or unwilling to provide signed consent for participation
  • and were unable or unwilling to meet study requirements for data collection and intervention purposes.
  • Within the month immediately preceding the screening visit, use of any form of tobacco or nicotine products other than cigarettes (e.g., e-cigarettes, chewing tobacco, etc.) on 3 or more days within a week if the individual refuses to refrain from such tobacco use during the course of the study
  • Current use of NRT or enrollment (or plans to enroll) in another smoking cessation program in the next 3 months
  • Uncontrolled hypertension (systolic blood pressure [SBP] greater than 180 or diastolic blood pressure [DBP] greater than 110)
  • History of severe cardiovascular (stroke, heart attack), kidney (e.g. chronic or acute kidney failure) or liver disease, or other unstable disease in the last 3 months
  • History of hypersensitivity or allergic reaction to NRT or similar chemical classes or any component of these formulations (including allergy to latex)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

32 participants in 2 patient groups

Motivational advice and free NRT
Experimental group
Treatment:
Behavioral: motivational advice
Drug: nicotine replacement therapy (NRT)
Quitline referral
Active Comparator group
Treatment:
Behavioral: Quitline referral

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems